BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32502018)

  • 1. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
    Wang L; Li J; Yang K; Zhang H; Wang Q; Lv X; Guan S
    Medicine (Baltimore); 2020 Jun; 99(23):e20548. PubMed ID: 32502018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
    Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
    J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
    Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.
    Huang R; Wang G; Tian C; Liu Y; Jia B; Wang J; Yang Y; Li Y; Sun Z; Yan X; Xia J; Xiong Y; Song P; Zhang Z; Ding W; Wu C
    Sci Rep; 2017 Aug; 7(1):8543. PubMed ID: 28819319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
    Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
    BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.
    Lee J; Kim MY; Kang SH; Kim J; Uh Y; Yoon KJ; Kim HS
    Br J Biomed Sci; 2018 Jul; 75(3):128-132. PubMed ID: 29893189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Lemoine M; Shimakawa Y; Nayagam S; Khalil M; Suso P; Lloyd J; Goldin R; Njai HF; Ndow G; Taal M; Cooke G; D'Alessandro U; Vray M; Mbaye PS; Njie R; Mallet V; Thursz M
    Gut; 2016 Aug; 65(8):1369-76. PubMed ID: 26109530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
    Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
    Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
    Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
    Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
    Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.
    Luo J; Du Z; Liang D; Li M; Yin Y; Chen M; Yang L
    J Clin Lab Anal; 2022 Aug; 36(8):e24596. PubMed ID: 35808928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W; Li Y; Geng J; Wang P; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.